Destiny Pharma (DEST): Corp Interims – extended cash runway into 2021 | Evgen Pharma (EVG): Corp Positive update from breast cancer STEM trial | Iofina (IOF): Corp Record results a taster of what’s to come |Omega Diagnostics (ODX): Corp Full-year results – VISITECT visibility

23 Sep 2019
Morning Note – 23 September 2019

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 23 September 2019
- Published:
23 Sep 2019 -
Author:
Mark Brewer | Jonathan Wright -
Pages:
7 -
Destiny Pharma (DEST): Corp Interims – extended cash runway into 2021 | Evgen Pharma (EVG): Corp Positive update from breast cancer STEM trial | Iofina (IOF): Corp Record results a taster of what’s to come |Omega Diagnostics (ODX): Corp Full-year results – VISITECT visibility